We found that Orai1 knockdown in PAH-hPECs induces increased BMPR2 expression, suggesting that Orai1 inhibition should partly reduce endothelial dysfunction that occurs in PAH by restoring BMPR2 expression. Here, ORAI1 is linked to pulmonary arterial hypertension.